ConductScience.org, home

Paper20204473

Basic PK/PD principles of drug effects in circular/proliferative systems for disease modelling.

Jacqmin P and 2 others. J Pharmacokinet Pharmacodyn, 2010. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Basic PK/PD principles of drug effects in circular/proliferative systems for disease modelling. Papers, record 20204473. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20204473

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Basic PK/PD principles of drug effects in circular/proliferative systems for disease modelling.
PubMed
Journal
J Pharmacokinet Pharmacodyn
PubMed
Year
2010
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.4
iCite
Revised in PubMed
2021-03-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jacqmin PPhilippe
2McFadyen LLynn
3Wade JRJanet R

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Disease ProgressionMajor topic
Models, BiologicalMajor topic
PharmacokineticsMajor topic
PharmacologyMajor topic
Antiviral Agents
Humans
Logistic Models
Microbial Sensitivity Tests
Viral Load
Virus Diseases

Source PubMed

Download CSV of topics

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116786410A non-linear mixed effect dynamic model incorporating prior exposure and adherence to treatment to describe long-term therapy outcome in HIV-patients.J Pharmacokinet Pharmacodyn2006https://conductscience.org/library/papers/16786410PubMed
211391158Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells.J Acquir Immune Defic Syndr2001https://conductscience.org/library/papers/11391158PubMed
311362021Models of viral kinetics and drug resistance in HIV-1 infection.AIDS Patient Care STDS1998https://conductscience.org/library/papers/11362021PubMed
411714222What do we really know about antibiotic pharmacodynamics?Pharmacotherapy2001https://conductscience.org/library/papers/11714222PubMed
516625427Disease progression and pharmacodynamics in Parkinson disease - evidence for functional protection with levodopa and other treatments.J Pharmacokinet Pharmacodyn2006https://conductscience.org/library/papers/16625427PubMed
617522597Model-based drug development.Clin Pharmacol Ther2007https://conductscience.org/library/papers/17522597PubMed
717067280Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis.Annu Rev Pharmacol Toxicol2007https://conductscience.org/library/papers/17067280PubMed
89059598Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations.J Theor Biol1997https://conductscience.org/library/papers/9059598PubMed
911698693Use of a stochastic model to develop understanding of the impact of different patterns of antiretroviral drug use on resistance development.AIDS2001https://conductscience.org/library/papers/11698693PubMed
1016918905Hierarchical Bayesian methods for estimation of parameters in a longitudinal HIV dynamic system.Biometrics2006https://conductscience.org/library/papers/16918905PubMed
1117632539Pharmacometrics and the transition to model-based development.Clin Pharmacol Ther2007https://conductscience.org/library/papers/17632539PubMed
1211264471Drug treatment effects on disease progression.Annu Rev Pharmacol Toxicol2001https://conductscience.org/library/papers/11264471PubMed
139192676Virus dynamics and drug therapy.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9192676PubMed
1411905835Modelling viral and immune system dynamics.Nat Rev Immunol2002https://conductscience.org/library/papers/11905835PubMed
1518333871A receptor theory-based semimechanistic PD model for the CCR5 noncompetitive antagonist maraviroc.Br J Clin Pharmacol2008https://conductscience.org/library/papers/18333871PubMed
1616078133Bridging the pharmacokinetics and pharmacodynamics of UK-279,276 across healthy volunteers and stroke patients using a mechanistically based model for target-mediated disposition.Pharm Res2005https://conductscience.org/library/papers/16078133PubMed
179857349Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up.J Viral Hepat1998https://conductscience.org/library/papers/9857349PubMed
1811462181Initial virological and immunologic response to highly active antiretroviral therapy predicts long-term clinical outcome.Clin Infect Dis2001https://conductscience.org/library/papers/11462181PubMed
1916849193Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patients.J R Soc Interface2005https://conductscience.org/library/papers/16849193PubMed
2017515923Top-down versus bottom-up-rediscovering physiology via systems biology?Mol Syst Biol2007https://conductscience.org/library/papers/17515923PubMed

See all 33 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42572208Viral Dynamic Model-Informed Dose Selection of Mosnodenvir Prophylaxis against DENV-3 in a Controlled Human Infection Model.Clin Pharmacol Ther2026https://conductscience.org/library/papers/42572208PubMed
36182824Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach.EBioMedicine2022https://conductscience.org/library/papers/36182824PubMed
34620860SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques.Nat Commun2021https://conductscience.org/library/papers/34620860PubMed
32144791Model-based meta-analysis of individual International Prostate Symptom Score trajectories in patients with benign prostatic hyperplasia with moderate or severe symptoms.Br J Clin Pharmacol2020https://conductscience.org/library/papers/32144791PubMed
28550375Exploring inductive linearization for pharmacokinetic-pharmacodynamic systems of nonlinear ordinary differential equations.J Pharmacokinet Pharmacodyn2018https://conductscience.org/library/papers/28550375PubMed
25288257Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshop.J Pharmacokinet Pharmacodyn2014https://conductscience.org/library/papers/25288257PubMed
23945605Assessment of Maraviroc Exposure-Response Relationship at 48 Weeks in Treatment-Experienced HIV-1-Infected Patients in the MOTIVATE Studies.CPT Pharmacometrics Syst Pharmacol2013https://conductscience.org/library/papers/23945605PubMed
23933716On translation of antibody drug conjugates efficacy from mouse experimental tumors to the clinic: a PK/PD approach.J Pharmacokinet Pharmacodyn2013https://conductscience.org/library/papers/23933716PubMed
23713816Clinical pharmacology = disease progression + drug action.Br J Clin Pharmacol2015https://conductscience.org/library/papers/23713816PubMed
22773164From in vitro EC₅₀ to in vivo dose-response for antiretrovirals using an HIV disease model. Part II: application to drug development.J Pharmacokinet Pharmacodyn2012https://conductscience.org/library/papers/22773164PubMed
22736302From in vitro EC₅₀ to in vivo dose-response for antiretrovirals using an HIV disease model. Part I: a framework.J Pharmacokinet Pharmacodyn2012https://conductscience.org/library/papers/22736302PubMed
21253559A novel approach to pharmacodynamic assessment of antimicrobial agents: new insights to dosing regimen design.PLoS Comput Biol2011https://conductscience.org/library/papers/21253559PubMed
21088872The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects.J Pharmacokinet Pharmacodyn2011https://conductscience.org/library/papers/21088872PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20204473

GET https://conductscience.org/api/papers/v1/20204473/references?page=2